Henoch-Schonlein purpura

Archives of Disease in Childhood

Volumn 80, Issue 4, 1999, Pages 380-383

  Tizard, E J ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIPYRIDAMOLE; IMMUNOGLOBULIN A; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; BIOLOGICAL MARKER;

ANAPHYLACTOID PURPURA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HUMAN; INTESTINE ISCHEMIA; KIDNEY DISEASE; ONSET AGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PURPURA; RASH; REVIEW; SYMPTOM; SYNDROME DELINEATION; CHILD; IMMUNOLOGY;

BIOLOGICAL MARKERS; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS; PURPURA, SCHOENLEIN-HENOCH;

EID: 0032588664     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.80.4.380     Document Type: Review

References (34)

1. Stewart M, Savage JM, Bell B, McCord B. Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population. Eur J Pediatr 1988;147:113-15.
2. Neilsen HE. Epidemiology of Schönlein-Henoch purpura. Acta Paediatr Scand 1988;77:125-31.
3. Robson WLM, Leung AKC. Henoch-Schönlein purpura. Advances in Pediatrics 1994;41:163-94.
4. Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arth Rheum 1990;33:1114-21.
5. Meadow SR. The prognosis of Henoch Schönlein nephritis. Clin Nephrol 1978;9:87-90.
6. Meadow SR, Glasgow EF, White RHR, Moncrieff MW, Cameron JS, Ogg CS. Schönlein-Henoch nephritis. Q J Med 1972;41:241-58.
7. Ha T-S, Cha S-H. Cerebral vasculitis in Henoch-Schönlein purpura: a case report with sequential magnetic resonance imaging. Pediatr Nephrol 1996;10:634-6.
8. Ostergaard JR, Storm K. Neurologic manifestations of Schönlein-Henoch purpura. Acta Paediatr Scand 1991;80:339-42.
9. Chaussain M, de Boissieu D, Kalifa G, et al. Impairment of lung diffusion capacity in Schönlein-Henoch purpura. J Pediatr 1992;121:12-16
10. 1 rheumatoid factor in the formation of IgA-containing immune complexes in Henoch-Schönlein purpura. J Clin Lab Immunol 1987;23:123-7.
11. Ronda N, Esnault VLM, Layward L, et al. Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura. Clin Exp Immunol 1994;95:49-55.
12. Lin J-J, Stewart CL, Kaskel FJ, Fine RN. IgG and IgA classes of anti-neutrophil cytoplasmic antibodies in a 13 year old girl with recurrent Henoch-Schönlein purpura. Pediatr Nephrol 1993;7:143-6.
13. Fujieda M, Oishi N, Naruse K, et al. Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schönlein purpura. Arch Dis Child 1998;78:240-4.
14. Hughes FJ, Wolfish NM, McLaine PN. Henoch-Schönlein syndrome and IgA nephropathy: a case report suggesting a common pathogenesis. Pediatr Nephrol 1988;2:389-92.
15. Meadow SR, Scott DG. Berger disease: Henoch Schönlein syndrome without the rash. J Pediatr 1985;106:27-32.
16. Smith GC, Davidson JE, Hughes DA, Holme E, Beattie TJ. Complement activation in Henoch-Schönlein purpura. Pediatr Nephrol 1997;11:477-80.
17. Ates E, Bakkaloglu A, Saatci U, Soylemezoglu O. Von Willebrand factor antigen compared with other factors in vasculitic syndromes. Arch Dis Child 1994;70:40-3.
18. De Mattia D, Penza R, Giordano P, et al. Von Willebrand factor and factor XIII in children with Henoch-Schönlein purpura. Pediatr Nephrol 1995;9:603-5.
19. Counahan R, Winterborn MH, White RHR, et al. Prognosis of Henoch-Schönlein nephritis in children. BMJ 1977;ii:11-14.
20. Saulsbury FT. Case report: antinuclear antiboby in Henoch-Schönlein purpura. Am J Med Sci 1986;291:180-2.
21. Rosenblum ND, Winter HS. Steroid effects on the course of abdominal pain in Henoch-Schönlein purpura. Pediatrics 1987;79:1081-21.
22. Mollica F, LiVolti S, Garozzo R, Russo G. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 1992;151:140-4.
23. Saulsbury FT. Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura. Pediatr Nephrol 1993;7:69-71.
24. Kaku Y, Nohara K, Honda S. Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors. Kidney Int 1998;53:1755-9.
25. Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch purpura nephritis. Pediatr Nephrol 1998;12:238-43.
26. Oner A, Tinaztepe K, Erdogan O. The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis. Pediatr Nephrol 1995;9:6-10.
27. Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N. Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol 1998;12:244-8.
28. Gianviti A, Trompeter RS, Barratt TM, Lythgoe MF, Dillon MJ. Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis. Arch Dis Child 1996;75:186-90.
29. Jardim HM, Leake J, Risdon RA, Barratt TM, Dillon MJ. Crescentic glomerulonephritis in children. Pediatr Nephrol 1992;6:231-5.
30. Koskimies O, Mir S, Rapola J, Vilska J. Henoch-Schönlein nephritis: long term prognosis of unselected patients. Arch Dis Child 1981;56:482-4.
31. Goldstein AR, White RHR, Akuse R, Chantler C. Long term follow-up of childhood Henoch-Schönlein nephritis. Lancet 1992;339:280-2.
32. Bunchman TE, Mauer SM, Sibley RK, Vernier RL. Anaphylactoid purpura: characteristics of 16 patients who progressed to renal failure. Pediatr Nephrol 1988;2:393-7.
33. Meulders Q, Pirson Y, Cosyns J-P, Squifflet J-P, van Ypersele de Strihou C. Course of Henoch-Schönlein nephritis after renal transplantation. Transplantation 1994;58:1179-86.
34. White RHR. Henoch-Schönlein purpura. In: Churg A, Churg J, eds. Systemic vasculitides. New York: Igaku-Shoin 1991:203-17.